Evaluation of the Impact of the VHA National Precision Oncology Program (NPOP) on Prior Authorization Adjudication of Targeted Anti-Cancer AgentsSeptember 23, 2021Oncology
Most community-based oncologists skip biomarker testingSeptember 21, 2021Lung CancerOncologyGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMelanoma
FDA approves first oral drug for NSCLC with EGFR Exon 20 insertionSeptember 20, 2021Lung CancerOncology
Immunotherapy for cancer patients with poor PS needs a rethinkSeptember 20, 2021Breast CancerOncologyLung CancerGenitourinary CancerLeukemia, Myelodysplasia, TransplantationMelanoma
Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-free DNASeptember 10, 2021Prostate CancerColon and RectalOncology
Prevalence and Management of Veterans with Advanced Solid Tumors Harboring NTRK Gene RearrangementsSeptember 10, 2021Oncology
